Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Abstract
The pathogenesis of inflammatory bowel disease (IBD) is multifactorial with data suggesting the role of a disturbed interaction between the gut and the intestinal microbiota. A defective mucosal barrier may result in increased intestinal permeability which promotes the exposition to luminal content and triggers an immunological response that promotes intestinal inflammation. IBD patients display several defects in the many specialized components of mucosal barrier, from the mucus layer composition to the adhesion molecules that regulate paracellular permeability. These alterations may represent a primary dysfunction in Crohn's disease, but they may also perpetuate chronic mucosal inflammation in ulcerative colitis. In clinical practice, several studies have documented that changes in intestinal permeability can predict IBD course. Functional tests, such as the sugar absorption tests or the novel imaging technique using confocal laser endomicroscopy, allow an in vivo assessment of gut barrier integrity. Antitumor necrosis factor-α (TNF-α) therapy reduces mucosal inflammation and restores intestinal permeability in IBD patients. Butyrate, zinc, and some probiotics also ameliorate mucosal barrier dysfunction but their use is still limited and further studies are needed before considering permeability manipulation as a therapeutic target in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Confocal laser endomicroscopy images from a healthy subject (a) and an Ulcerative Colitis (UC) patient with inactive disease (b). UC patients display increased crypt diameter, intercryptic distance, and perivascular fluorescence. Courtesy of Dr. A. Buda and with permission of Journal of Crohn's and Colitis [105]; © inclusion under a Creative Commons license or any other open-access license allowing onward reuse is prohibited.](https://figures.cochat.ai/paper-figures/2164d4b5b56e4db78a431b3045efb19f/intestinal-permeability-in-inflammatory-bowel-disease-pathogenesis-clinical-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This condition, known as intestinal permeability or leaky gut, has been implicated in the pathophysiology of various GI, as well as extraintestinal disorders [120,121,122], including PD [117,123,124,125,126,127,128]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · cited 5×
“As a matter of fact several defects in bacterial recognition and processing have been documented in CD patients carrying particular genetic polymorphisms, chiefly of pattern-recognition receptors such as NOD2/CARD15 [68, 69] and genes involved in autophagy like ATG16L1 and IRGM [70–72].”
BackgroundInfluentialA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 1×
“[9] “permeability” is defined as a functional feature of this barrier that on one hand allows the coexistence with bacterial symbionts necessary for our organism and on the other hand prevents luminal penetration of macromolecules and pathogens [10, 11].”
BackgroundReview article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721
Genetics and pathogenesis of inflammatory bowel disease
Khor, B., Gardet, A., & Xavier, R. J. (2011) · Nature · doi:10.1038/nature10209 · Cited by 2,614
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436 · cited 1×
“It is estimated that the total bacterial cell count in our body exceeds ten times the total number of human cells, with more than one thousand species hosted in the gastrointestinal tract [1, 2].”
BackgroundMachiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904 · cited 1×
“Another potential mechanism of action is the restoration of butyrate-producing bacteria: UC patients have reduced bacterial species like Faecalibacterium prausnitzii [133, 139] and supplementation with butyrate-producing species or probiotics along with preformed butyrate showed efficacy in experimental models [140, 1…”
BackgroundHampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La Vega, F. M., Briggs, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1954 · Cited by 1,897
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775 · cited 1×
“The mechanical cohesion of these cells and the regulation of paracellular permeability of ions and smallmolecules are ensured by three types of junctional complexes, namely, tight junctions (TJs), adherence junctions, and desmosomes [24, 26, 27].”
BackgroundIntestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755 · cited 6×
“Both the probes are equally affected by gastrointestinal dilution, motility, bacterial degradation, and renal function; thus, the ratio allows for correcting possible confounding factors [9, 82].”
BackgroundInfluential
Research works printed but not linked: 1
- D'Incà R. Di Leo V. Martines D. Can permeability to sugars predict relapses in Crohn's disease? Gut 1993 34 1, supplement S50 S73
Cited by
Items 101–200 of 759
He, S., Guo, Y., Zhao, J., Xu, X., Wang, N., & Liu, Q. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00376 · Cited by 87
“Dysfunction of intestinal epithelial barrier may lead to increased permeability of intestinal mucosa, subsequent translocation of intestinal pathogenic bacteria or toxins, which in turn aggravates the damage of intestinal barrier integrity, resulting in local intestinal or systemic disease such as inflammatory bowel d…”
BackgroundLai, Y., Xue, J., Liu, C.-W., Gao, B., Chi, L., Tu, P., Lu, K., & Ru, H. (2019) · Molecules · doi:10.3390/molecules24030449 · Cited by 80
“The increase is likely due to elevated intake of caffeine, a compromise in their metabolizing capacity, and a leaky gut in the diseased that allow intestinal caffeine metabolites to come across and reach the circulation system [66].”
BackgroundPeters, M. F., Choy, A. L., Pin, C., Leishman, D. J., Moisan, A., Ewart, L., Guzzie-Peck, P. J., Sura, R., Keller, D. A., Scott, C. W., et al. (2020) · Lab on a Chip · doi:10.1039/c9lc01107b · Cited by 76
Liang, L., Saunders, C., & Sanossian, N. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3229 · Cited by 85
Henriksen, M., Høivik, M. L., Jelsness‐Jørgensen, L., Moum, B. A., & IBSEN Study Group (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx152 · Cited by 84
Alard, J., Peucelle, V., Boutillier, D., Breton, J., Kuylle, S., Pot, B., Holowacz, S., & Grangette, C. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0097 · Cited by 78
“Whether defect in the mucosal barrier is a consequence of the inflammatory response or a primary event that prompts mucosal inflammation is still under debate (Michielan and D’Inca, 2015).”
BackgroundPhysiopathology of intestinal barrier and the role of zonulin
Caviglia, G. P., Rosso, C., Ribaldone, D. G., Dughera, F., Fagoonee, S., Astegiano, M., & Pellicano, R. (2019) · Minerva Biotecnologica · doi:10.23736/s1120-4826.19.02554-0 · Cited by 82
“6 intercellular connections are necessary for the mechanical cohesion of the cells, to define the boundary between the apical and basolateral region of the membrane, and also for the regulation of the permeability of the paracellular transport pathway.(21) The epithelium of the small intestine is characterized by the…”
BackgroundTremellen, K. (2016) · Basic and Clinical Andrology · doi:10.1186/s12610-016-0034-7 · Cited by 73
“In addition, it would also be interesting to correlate direct measures of intestinal permeability, such as sugar absorption tests [113], with changes in testicular function.”
BackgroundCasado-Bedmar, M., & Viennois, E. (2022) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjab223 · Cited by 77
The role of mucosal barriers in human gut health
Seo, K., Seo, J.-M., Yeun, J., Choi, H., Kim, Y., & Chang, S.-Y. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01327-5 · Cited by 82
“This dysbiosis disrupts the balanced microbial composition and accumulates bacterial toxins such as LPS. IBD patients have higher intestinal permeability than healthy groups (Michielan and D’Inca 2015).”
BackgroundAttenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease
Wilson, A., Almousa, A., Teft, W. A., & Kim, R. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-58644-w · Cited by 73
Dietary Carbohydrates and Lipids in the Pathogenesis of Leaky Gut Syndrome: An Overview
Binienda, A., Twardowska, A., Makaro, A., & Sałaga, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218368 · Cited by 85
Hudson, L. E., Anderson, S. E., Corbett, A. H., & Lamb, T. J. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00049-16 · Cited by 88
“ogy and may serve as a potential novel therapeutic target (211).”
BackgroundChe, L., Xu, Q., Wu, C., Luo, Y., Huang, X., Zhang, B., Auclair, E., Kiros, T. G. G., Fang, Z., Lin, Y., et al. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517003051 · Cited by 80
“The intestinal bacteria has been shown to target various intracellular process including the expression and distribution of tight junction proteins, thereby modulating the intestinal permeability((39)) and gastrointestinal diseases((40,41)).”
BackgroundBui, T. M., Mascarenhas, L., & Sumagin, R. (2018) · Tissue Barriers · doi:10.1080/21688370.2018.1431038 · Cited by 81
“As such, mislocalization/ loss of several key components of the AJCs including, E-cadherin, Occludin, Claudin-1, Zonula Occluden-1 (ZO-1), and Junctional Adhesion Molecule-A (JAM-A) adjacent to clusters of transmigrating neutrophils was reported in clinical samples obtained from patients with IBD and cultured IECs.(59…”
BackgroundInfluentialGaifem, J., Mendes‐Frias, A., Wolter, M., Steimle, A., Garzón, M. J., Úbeda, C., Nobre, C., González, A., Pinho, S. S., Cunha, C., et al. (2024) · mBio · doi:10.1128/mbio.00078-24 · Cited by 77
“Although exacerbated intestinal permeability is known to be a hallmark in IBD and is found in IBD patients (31), no significant differences were found in the intestinal permeability among the two groups of mice at homeostasis (Fig.”
BackgroundZhao, H., Xu, H., Chen, S., He, J., Zhou, Y., & Nie, Y. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15222 · Cited by 83
A new horizon of precision medicine: combination of the microbiome and extracellular vesicles
Yang, J., Shin, T.-S., Kim, J. S., Jee, Y., & Kim, Y. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00748-6 · Cited by 77
Inflammation, Autoinflammation and Autoimmunity in Inflammatory Bowel Diseases
Padoan, A., Musso, G., Contran, N., & Basso, D. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45070350 · Cited by 80
Contribution of Zinc and Zinc Transporters in the Pathogenesis of Inflammatory Bowel Diseases
Ohashi, W., & Fukada, T. (2019) · Journal of Immunology Research · doi:10.1155/2019/8396878 · Cited by 69
Qu, L., Liu, C., Ke, C., Zhan, X., Li, L., Xu, H., Xu, K., & Liu, Y. (2022) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x22500203 · Cited by 78
Bacteriophages and the One Health Approach to Combat Multidrug Resistance: Is This the Way?
Garvey, M. (2020) · Antibiotics · doi:10.3390/antibiotics9070414 · Cited by 81
“Alterations in the gut microbiota termed dysbiosis have also been associated with the pathogenesis of systemic conditions, including obesity, metabolic syndrome [56], and systemic rheumatic diseases such as rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, ankylosing spondylitis, and Sjögren’s sy…”
BackgroundThe Effects of Blueberry Phytochemicals on Cell Models of Inflammation and Oxidative Stress
Lavefve, L., Howard, L. R., Adams, S. H., & Baum, J. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab137 · Cited by 76
Yu, W., Sun, S., Yan, Y., Zhou, H., Liu, Z., & Fu, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1519925 · Cited by 82
“Examples include adding methyl groups to cytosine and then adding guanosine (CpG site) to the sequence.”
Palmitic Acid Affects Intestinal Epithelial Barrier Integrity and Permeability In Vitro
Gori, M., Altomare, A., Cocca, S., Solida, E., Ribolsi, M., Carotti, S., Rainer, A., Francesconi, M. A., Morini, S., Cicala, M., et al. (2020) · Antioxidants · doi:10.3390/antiox9050417 · Cited by 76
Jang, H., Kim, J.-K., Joo, M.-K., Shin, Y.-J., Lee, C. K., Kim, H. J., & Kim, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-00088-x · Cited by 79
Guo, W. Y., Zeng, M., Zhu, S., Li, S., Qian, Y., & Wu, H. (2022) · Food & Function · doi:10.1039/d1fo02970c · Cited by 75
Arachidonate 15-lipoxygenase type B: Regulation, function, and its role in pathophysiology
Benatzy, Y., Palmer, M. A., & Brüne, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1042420 · Cited by 74
“As inflammatory bowel disease is characterized by an impaired permeability barrier (Michielan and D’Incà 2015), therapies targeting ALOX15B expression may help in the resolution.”
BackgroundThe Role of Gut Microbiota and Leaky Gut in the Pathogenesis of Food Allergy
Poto, R., Fusco, W., Rinninella, E., Cintoni, M., Kaitsas, F., Raoul, P. C., Caruso, C., Mele, M. C., Varricchi, G., Gasbarrini, A., et al. (2023) · Nutrients · doi:10.3390/nu16010092 · Cited by 83
“Because of the disruption of the gut barrier, IBDs are characterized by a considerably leaky gut [71,72].”
Disruption of female reproductive function by endotoxins
Bidne, K. L., Dickson, M. J., Ross, J. W., Baumgard, L. H., & Keating, A. F. (2018) · Reproduction · doi:10.1530/rep-17-0406 · Cited by 80
“Indeed ‘leaky gut’, and resultant metabolic endotoxemia, has been associated with many pathologies such as inflammatory bowel syndrome (Michielan & D’Inca 2015), cirrhosis (Fukui 2015, Lutz et al.”
BackgroundZhang, Z., Tanaka, I., Pan, Z., Ernst, P. B., Kiyono, H., & Kurashima, Y. (2022) · European Journal of Immunology · doi:10.1002/eji.202149532 · Cited by 69
Prevalence of Zinc Deficiency in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Zupo, R., Sila, A., Castellana, F., Bringiotti, R., Curlo, M., Pergola, G. D., Nucci, S. D., Giannelli, G., Mastronardi, M., & Sardone, R. (2022) · Nutrients · doi:10.3390/nu14194052 · Cited by 70
“Zinc levels are often low in patients with chronic diarrhea and malabsorptive disorders [7].”
BackgroundLi, Y., Li, H., Wang, R., Yu, Y., Liu, X., & Tian, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114568 · Cited by 66
Rahman, S. U., Li, Y., Huang, Y., Zhu, L., Feng, S., Wu, J., & Wang, X. (2018) · Inflammopharmacology · doi:10.1007/s10787-018-0462-4 · Cited by 68
“In IBD, the gut epithelial lining or some portion is damaged which disturbed the absorbency of the mucosal obstacle and the absorption of the compounds by passing through the enterocytes starting some allergic responses which are scientifically described as “leaky gut syndrome” (Michielan and Inca 2015; Odenwald and T…”
BackgroundXiao, Y., Lian, H., Zhong, X. S., Krishnachaitanya, S. S., Cong, Y., Dashwood, R. H., Savidge, T., Powell, D. W., Liu, X., & Li, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1020902 · Cited by 66
Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease
Jergens, A. E., Parvinroo, S., Kopper, J., & Wannemuehler, M. J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.669913 · Cited by 63
Intestinal epithelial barrier and neuromuscular compartment in health and disease
D’Antongiovanni, V., Pellegrini, C., Fornai, M., Colucci, R., Blandizzi, C., Antonioli, L., & Bernardini, N. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i14.1564 · Cited by 64
The alleviating effect and mechanism of GLP-1 on ulcerative colitis
Wang, W., Zhang, C., Zhang, H., Li, L., Fan, T., & Jin, Z. (2023) · Aging · doi:10.18632/aging.204953 · Cited by 63
Selvamani, S., Mehta, V. K., Enshasy, H. A. E., Thevarajoo, S., Adawi, H. E., Zeini, I. M., Pham, K., Varzakas, T. H., & Abomoelak, B. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2022.02.044 · Cited by 66
“This alteration of the microbiome affects the interaction of the host’s homeostatic systems with lumen stimuli and eventually perpetuates uncontrolled inflammation in the intestinal mucosa that potentially leads to IBD (Alhagamhmad et al., 2016; Hoffmann et al., 2016; Michielan and D’Incà, 2015).”
BackgroundInfluentialJang, H., Kim, J.-K., Joo, M.-K., Shin, Y.-J., Lee, K., Lee, C. K., Kim, H. J., & Kim, D. (2022) · Scientific Reports · doi:10.1038/s41598-022-13629-9 · Cited by 63
Liu, X., Han, B., Xu, J., Zhu, J., Hu, J., Wan, W., & Miao, S. (2020) · Aquaculture Reports · doi:10.1016/j.aqrep.2020.100472 · Cited by 58
Dopamine promotes colonic mucus secretion through dopamine D 5 receptor in rats
Li, Y., Zhang, Y., Zhang, X., Feng, X., Liu, C., Zhang, X.-N., Quan, Z., Yan, J., & Zhu, J. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00261.2017 · Cited by 60
“Dysregulated mucus secretion would affect mucosal barrier, increase intestinal permeability (26), and result in intestinal mucosal inflammation, which is evident in patients with ulcerative colitis, Crohn’s disease (5), and gastrointestinal cancer (32).”
BackgroundKim, M. R., Cho, S.-Y., Lee, H. J., Kim, J. Y., Nguyen, U. T. T., Ha, N. M., Choi, K. Y., Hyun, K., Kim, J., Kim, W. K., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154209 · Cited by 58
Świrkosz, G., Szczygieł, A., Logoń, K., Wrześniewska, M., & Gomułka, K. (2023) · Biomedicines · doi:10.3390/biomedicines11123144 · Cited by 68
Bianchi, M. G., Chiu, M., Taurino, G., Brighenti, F., Rio, D. D., Mena, P. R., & Bussolati, O. (2019) · Nutrients · doi:10.3390/nu11102271 · Cited by 57
“Conversely, the effects of inflammatory cytokines on tight junctional complexes are the determinants of increased permeability in quiescent IBD and may constitute both a primary dysfunction and the factor responsible for the progression to chronic mucosal inflammation due the persistently activated macrophages [3].”
BackgroundPrebiotic, antioxidant and anti-inflammatory properties of edible Amazon fruits
Curimbaba, T. F. S., de Almeida, L. D., Chagas, A. S., Quaglio, A. E. V., Herculano, A. M., & Stasi, L. C. D. (2020) · Food Bioscience · doi:10.1016/j.fbio.2020.100599 · Cited by 62
Manipulation of Gut Microbiota as a Key Target for Crohn's Disease
Rashed, R. T., Valcheva, R. S., & Dieleman, L. A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.887044 · Cited by 59
Ren, D., Chen, K.-C., Li, S.-S., Zhang, Y.-T., Li, Z.-M., Liu, S., & Sun, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161625 · Cited by 55
Animal models of inflammatory bowel disease: category and evaluation indexes
Wen, C., Chen, D., Zhong, R., & Peng, X. (2023) · Gastroenterology report · doi:10.1093/gastro/goae021 · Cited by 64
“Defects in the mucosal barrier may lead to increased intestinal permeability [111].”
BackgroundBioavailability of arsenic, cadmium, lead and mercury as measured by intestinal permeability
Bolan, S. S., Seshadri, B., Keely, S., Kunhikrishnan, A., Bruce, J. K., Grainge, I., Talley, N. J., & Naidu, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-94174-9 · Cited by 53
Liu, W., Han, Y., An, J., Yu, S., Zhang, M., Li, L., Liu, X., & Li, H. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.142824 · Cited by 55
Kim, Y., Kessler, S. P., Obery, D. R., Homer, C. R., McDonald, C., & de la Motte, C. A. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.11.001 · Cited by 54
“Specifically, for IBD patients or babies with NEC where decreased ZO-1 levels are thought to contribute to the high incidence of bacterial infections, HA35 may be a generally safe prophylactic strategy to increase host defense [8,46,47].”
BackgroundNew Insights into the Role of Trace Elements in IBD
Gîlcă-Blanariu, G.-E., Diaconescu, S., Ciocoiu, M., & Ștefănescu, G. (2018) · BioMed Research International · doi:10.1155/2018/1813047 · Cited by 60
“Zinc is a trace element known for its role in cell turnover and repair systems, with studies showing that correcting zinc deficiency can lead to restoring intestinal permeability in CD patients, probably due to its ability to modulate tight junctions both in the small and the large bowel [35].”
BackgroundPai, Y.-C., Weng, L.-T., Wei, S., Wu, L., Shih, D. Q., Targan, S. R., Turner, J. R., & Yu, L. C. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa165 · Cited by 56
Shi, C., Yue, F., Shi, F., Qin, Q., Wang, L., Wang, G., Mu, L., Liu, D., Li, Y., Yu, T., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s288412 · Cited by 54
Le, N. P. K., Altenburger, M. J., & Lamy, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087427 · Cited by 55
Autoimmune phenotypes in schizophrenia reveal novel treatment targets
Severance, E. G., Dickerson, F., & Yolken, R. H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.05.005 · Cited by 58
“Intestinal permeability may also be improved with the SCFAs propionate and butyrate, and the polyunsaturated fatty acids, omega-3 fatty acids (Michielan & D'Inca, 2015) .”
Ursodeoxycholic acid: a promising therapeutic target for inflammatory bowel diseases?
Keely, S. J., Steer, C. J., & Lajczak, N. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00163.2019 · Cited by 53
Bosch, S., Struys, E. A., van Gaal, N., Bakkali, A., Jansen, E. E. W., Diederen, K., Benninga, M. A., Mulder, C. J. J., de Boer, N. K. H., & de Meij, T. G. J. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001812 · Cited by 52
The Link between Gut Dysbiosis Caused by a High-Fat Diet and Hearing Loss
Kociszewska, D., Chan, J., Thorne, P. R., & Vlajkovic, S. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413177 · Cited by 58
“IBD is an umbrella term used to describe disorders that involve chronic GI inflammation, such as Crohn’s disease (CD) and ulcerative colitis (UC) [52], which are also characterised by a leaky gut.”
BackgroundHolzreuter, M. A., & Segerink, L. I. (2024) · Lab on a Chip · doi:10.1039/d3lc00901g · Cited by 53
Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD
Termite, F., Archilei, S., D’Ambrosio, F., Petrucci, L., Viceconti, N., Iaccarino, R., Liguori, A., Gasbarrini, A., & Miele, L. (2025) · Antioxidants · doi:10.3390/antiox14010056 · Cited by 63
Increased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver Steatosis
Palo, D. M. D., Garruti, G., Ciaula, A. D., Molina‐Molina, E., Shanmugam, H., Angelis, M. D., & Portincasa, P. (2020) · Nutrients · doi:10.3390/nu12020564 · Cited by 52
“6) is an artificial sugar poorly absorbed in the human intestine, not degraded by intestinal bacteria, and useful in assessing the permeability of the entire intestinal tract [3] and colon [18] (Figure 1A–D).”
BackgroundChibuye, M., Mende, D. R., Spijker, R., Simuyandi, M., Luchen, C. C., Bosomprah, S., Chilengi, R., Schultsz, C., & Harris, V. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00517-5 · Cited by 54
Intestinal Barrier Function in Health and Disease—Any Role of SARS-CoV-2?
Sharma, L., & Riva, A. (2020) · Microorganisms · doi:10.3390/microorganisms8111744 · Cited by 51
“Additionally, a decrease in Paneth cell function has also been linked to the pathogenesis of Crohn’s disease [66].”
BackgroundYe, X., & Sun, M. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.2928 · Cited by 52
“Integrity of the intestinal epithelial barrier depends on a complex network of intercellular tight junctions (TJs) and cytoskeletal structures, and disruption of this network results in impaired barrier function (8-11).”
Wasiak, J., & Gawlik-Kotelnicka, O. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114459 · Cited by 47
Singh, V. K., Almpani, M., Maura, D., Kitao, T., Ferrari, L., Fontana, S., Bergamini, G., Calcaterra, E., Pignaffo, C., Negri, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32833-9 · Cited by 48
Circulating Microbial Cell-Free DNA in Health and Disease
Pietrzak, B., Kawacka, I., Olejnik‐Schmidt, A., & SCHMIDT, M. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033051 · Cited by 50
“In contrast, in IBD patients the gut microbiome was found to be the main source of the circulating cell-free microbiome, and it was suggested that intestinal bacteria could enter into the bloodstream due to the impaired mucosal barrier integrity that is commonly found in IBD patients [48].”
BackgroundUwada, J., Nakazawa, H., Muramatsu, I., Masuoka, T., & Yazawa, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076508 · Cited by 48
“Patients with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, often have impaired intestinal barrier function and exacerbated inflammation [1,2].”
BackgroundNeutrophils and NETs in Pathophysiology and Treatment of Inflammatory Bowel Disease
Ortega-Zapero, M., Gómez-Bris, R., Pascual-Laguna, I., Saéz, Á., & González, J. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157098 · Cited by 52
“In particular, NET-associated histones associate with tight junction complexes, destabilize junctional architecture, and trigger epithelial cell death, collectively increasing barrier leakiness [171–173].”
Orr, S. E., Gokulan, K., Boudreau, M. D., Cerniglia, C. E., & Khare, S. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0499-6 · Cited by 47
Liu, P., Bian, Y., Fan, Y., Zhong, J., & Liu, Z. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b06347 · Cited by 47
Mandour, M. A., Chen, S., & van de Sande, M. G. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.618581 · Cited by 50
Beneficial effects of dietary capsaicin in gastrointestinal health and disease
Xiang, Y., Xu, X.-L., Zhang, T., Wu, X., Fan, D., Hu, Y., Ding, J., Yang, X., Lou, J. Q., Du, Q., et al. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113227 · Cited by 49
Ferulic Acid as a Protective Antioxidant of Human Intestinal Epithelial Cells
Hwang, H.-J., Lee, S. R., Yoon, J.-G., Moon, H.-R., Zhang, J., Park, E., Yoon, S.-I., & Cho, J. A. (2022) · Antioxidants · doi:10.3390/antiox11081448 · Cited by 51
Hiengrach, P., Panpetch, W., Worasilchai, N., Chindamporn, A., Tumwasorn, S., Jaroonwitchawan, T., Wilantho, A., Chatthanathon, P., Somboonna, N., & Leelahavanichkul, A. (2019) · Shock · doi:10.1097/shk.0000000000001339 · Cited by 46
“Although the influence of gut bacteria in IBD has been thoroughly studied (12), fewer studies have been reported on the gut fungi in IBD (4).”
BackgroundResultHasegawa, T., Mizugaki, A., Inoue, Y., Kato, H., & Murakami, H. (2021) · Amino Acids · doi:10.1007/s00726-021-03001-y · Cited by 46
Szymańska, E., Wierzbicka, A., Dądalski, M., & Kierkuś, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173905 · Cited by 52
“Introduction Recent studies on the pathogenesis of inflammatory bowel disease (IBD)—Crohn’s disease (CD) and ulcerative colitis (UC)—indicate a significant role of increased intestinal epithelial permeability in disease development [1].”
BackgroundKopper, J. J., Iennarella‐Servantez, C. A., Jergens, A. E., Sahoo, D. K., Guillot, E., Bourgois‐Mochel, A., Martinez, M. N., Allenspach, K., & Mochel, J. P. (2021) · Frontiers in Toxicology · doi:10.3389/ftox.2021.773953 · Cited by 48
Sharpton, T., Lyalina, S., Luong, J., Pham, J., Deal, E. M., Armour, C., Gaulke, C., Sanjabi, S., & Pollard, K. S. (2017) · mSystems · doi:10.1128/msystems.00036-17 · Cited by 45
“survive inside of an inflamed gut or invade the host given that intestinal permeability frequently 380 increases during IBD flare-ups (99).”
BackgroundMast Cells in Irritable Bowel Syndrome: A Systematic Review
Krammer, L., Sowa, A. S., & Lorentz, A. (2019) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-229 · Cited by 49
Kim, Y.-R., Volpert, G., Shin, K., Kim, S., Shin, S., Lee, Y., Sung, S. H., Lee, Y., Ahn, J., Pewzner‐Jung, Y., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13267 · Cited by 44
Liu, H., Gu, R., Li, W., Zhou, W., Cong, Z., Xue, J., Liu, Y., Wei, Q., & Zhou, Y. (2019) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622319860653 · Cited by 48
Pharmacokinetic and pharmacodynamic insights from microfluidic intestine-on-a-chip models
Lee, S. H., Choi, N., & Sung, J. H. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1700950 · Cited by 45
Wang, Y., Wen, R., Liu, D., Zhang, C., Wang, Z. A., & Du, Y. (2021) · Molecules · doi:10.3390/molecules26082199 · Cited by 45
“Hence, it has become another pathogenic factor of IBD [7].”
BackgroundGut permeability and its clinical relevance in schizophrenia
Ishida, I., Ogura, J., Aizawa, E., Ota, M., Hidese, S., Yomogida, Y., Matsuo, J., Yoshida, S., & Kunugi, H. (2022) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12227 · Cited by 46
Celiberto, L. S., Pinto, R. A., Rossi, E. A., Vallance, B. A., & Cavallini, D. C. U. (2018) · Nutrients · doi:10.3390/nu10111684 · Cited by 39
Kim, J. Y., Le, T. A. N., Lee, S. Y., Song, D., Hong, S.-C., Hyun, K., Lee, J. W., Pan, C., & Kang, K. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b03039 · Cited by 43
Serine proteases at the cutting edge of IBD: Focus on gastrointestinal inflammation
Kriaa, A., Jablaoui, A., Mkaouar, H., Akermi, N., Maguin, E., & Rhimi, M. (2020) · The FASEB Journal · doi:10.1096/fj.202000031rr · Cited by 45
Rallabandi, H. R., Yang, H., Oh, K. B., Lee, H.-C., Byun, S. J., & Lee, B. R. (2020) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-020-00278-0 · Cited by 43
Pharmacologic treatment of GERD: Where we are now, and where are we going?
Scarpignato, C., Hongo, M., Wu, J. C. Y., Lottrup, C., Lazarescu, A., Stein, E. M., & Hunt, R. H. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14473 · Cited by 47
Dysbiosis of Gut Microbiome and Its Impact on Epigenetic Regulation
Lee, E. S., Song, E., & Nam, Y. D. (2017) · Journal of Clinical Epigenetics · doi:10.21767/2472-1158.100048 · Cited by 46
Derangement of intestinal epithelial cell monolayer by dietary cholesterol oxidation products
Deiana, M., Calfapietra, S., Incani, A., Atzeri, A., Rossin, D., Loi, R., Sottero, B., Iaia, N., Poli, G., & Biasi, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.390 · Cited by 42
Tenore, G. C., Pagano, E., Lama, S., Vanacore, D., Maro, S. D., Maisto, M., Capasso, R., Merlino, F., Borrelli, F., Stiuso, P., et al. (2019) · Nutrients · doi:10.3390/nu11030610 · Cited by 44
“Recently, intestinal permeability has been recognized as a new target for IBD prevention and therapy [4,5].”
BackgroundInfluentialFabbro, S. D., Calder, P. C., & Childs, C. E. (2020) · Proceedings of The Nutrition Society · doi:10.1017/s0029665120006953 · Cited by 43
“…barrier and enter in direct contact with gut and systemic immune cells when the gut is immature, such as in infants (25,26) , or in other situations characterised by increased gut permeability, such as IBD (27) , obesity (28,29) , type 1 diabetes (30) and non-alcoholic fatty liver disease (31) .”
Influence of Dietary Patterns on Plasma Soluble CD14, a Surrogate Marker of Gut Barrier Dysfunction
Tabung, F. K., Birmann, B. M., Epstein, M. M., Martínez-Maza, O., Breen, E. C., Wu, K., & Giovannucci, E. L. (2017) · Current Developments in Nutrition · doi:10.3945/cdn.117.001396 · Cited by 41
Dietary and enteral interventions for Crohn's disease
Yamamoto, T., Shimoyama, T., & Kuriyama, M. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.11.011 · Cited by 45
Byelinska, I. V., Kuznietsova, H. M., Dziubenko, N., Lynchak, O. V., Rybalchenko, T., Prylutskyy, Y. І., Kyzyma, O. A., Ivankov, O. I., Rybalchenko, V. K., & Ritter, U. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.08.033 · Cited by 42
Three-tissue microphysiological system for studying inflammatory responses in gut-liver Axis
Jeon, J., Choi, N., Lee, S. H., & Sung, J. H. (2020) · Biomedical Microdevices · doi:10.1007/s10544-020-00519-y · Cited by 41
Metadata
- Authors
- Michielan, A., & D’Incà, R.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Michielan, Andrea
- ORCID
- Michielan, Andrea
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2015-01
- Volume
- 2015
- Issue
- 1
- Pages
- 628157-628157
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC4637104
- OpenAlex
- W2176502392
- Cited by
- 709
- References
- 146
- Citations by year
- 2026: 61 · 2025: 54 · 2024: 86 · 2023: 91 · 2022: 99 · 2021: 82 · 2020: 81 · 2019: 58 · 2018: 38 · 2017: 37 · 2016: 21
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Oxford
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- intestinal permeability, leaky gut, inflammatory bowel disease, Crohn's disease, ulcerative colitis, mucosal barrier dysfunction, gut microbiota, mucus layer, paracellular permeability, adhesion molecules, confocal laser endomicroscopy, butyrate, zinc, probiotics, intestinal inflammation
- MeSH terms
- Humans, Intestinal Mucosa, Permeability, Tumor Necrosis Factor-alpha, Zinc, Inflammatory Bowel Diseases, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.